About the Business
With a rich background as a Chief Financial Officer (CFO), Aleksey Krylov is
a seasoned professional with in-depth expertise in the dynamic arenas of life
sciences and medical technology. Aleksey presents a remarkable portfolio of
over 70 successful fundraising and M&A transactions, showcasing his
adeptness in steering companies through diverse strategic opportunities.
Holding an MBA from Columbia Business School and a Bachelor of Science in
Business Administration from Babson College, Aleksey’s financial acumen is
further illuminated in his transformative role as the CFO of CytoImmune
Therapeutics where he secured over $100 million in funding.
As the CFO of DIH International, Aleksey Krylov strategically
positioned the Swiss-Chinese medical equipment manufacturer for a NASDAQ public
offering, emphasizing growth optimization and maximizing shareholder value. At
SELLAS Life Sciences, he led a successful reverse merger, propelling the
company to a market capitalization of several hundred million dollars. He also
took care of investments of over $500 million across diverse industries as a
family office investment professional.
Aleksey Krylov considers himself
fortunate for his career success and entrepreneurial ventures. Driven by a
desire to give back, he seeks to share ideas and thoughts that could benefit
fellow entrepreneurs on their journeys. Aleksey Krylov’s impressive track
record as a CFO not only witnesses his financial prowess but also proves his
strong commitment to fostering growth and innovation in the business world.
Reviews (0)
Click to RatePublisher Info
- With a rich background as a Chief Financial Officer (CFO), Aleksey Krylov is a seasoned professional with in-depth expertise in the dynamic arenas of life sciences and medical technology. Aleksey presents a remarkable portfolio of over 70 successful fundraising and M&A transactions, showcasing his adeptness in steering companies through diverse strategic opportunities. Holding an MBA from Columbia Business School and a Bachelor of Science in Business Administration from Babson College, Aleksey's financial acumen is further illuminated in his transformative role as the CFO of CytoImmune Therapeutics where he secured over $100 million in funding. As the CFO of DIH International, Aleksey strategically positioned the Swiss-Chinese medical equipment manufacturer for a NASDAQ public offering, emphasizing growth optimization and maximizing shareholder value.
- +16463274134
- Aleksey Krylov
- 100 Church Street 8th floor, New York, NY 10007
- Visit Website
Opening Time
-
Mon
12:00 AM - 11:30 PM
-
Tue
12:00 AM - 11:30 PM
-
Wed
12:00 AM - 11:30 PM
-
Thu
12:00 AM - 11:30 PM
-
Fri
12:00 AM - 11:30 PM
-
Sat
12:00 AM - 11:30 PM
-
Sun
12:00 AM - 11:30 PM